Clinical Trials Logo

Clinical Trial Summary

The protocol has many assets. A prospective nationwide recruitment allows for the inclusion of a large cohort of patients with UIA. It will combine accurate clinical phenotyping and comprehensive imaging with CAWE screening. Besides, it will enable to exploit metadata and to explore new pathophysiological pathways of interest by crossing clinical, genetic, biological, and imaging information.


Clinical Trial Description

Management of small (<7mm) unruptured intracranial aneurysms (UIA) remains controversial. Previous retrospective studies have suggested that post gadolinium arterial wall enhancement (AWE) of unruptured intracranial aneurysms on MR imaging may reflect aneurysm wall instability, and hence may highlight a higher risk of UIA growth over time. This multicentric prospective cohort aims at exploring vessel wall imaging findings of UIAs with consecutive follow-up to substantiate these assumptions.The objective is to develop diagnostic and predictive tools for the risk of IA evolution. The aim is to demonstrate in clinical practice the predictive value of (AWE) for UIA growth. The growth will be determined by any modification of the UIA measurement. Both UIA growth and the UIA wall enhancement will be assessed in consensus by two expert neuroradiologists.The French prospective UCAN project is a non-interventional international wide and multicentric prospective cohort. UIA of bifurcation between 3 and 7 mm for whom a clinical and imaging follow-up without occlusion treatment was scheduled by local multidisciplinary staff will be included. Extensive clinical, biological and imaging data will be recorded during a 3 years follow-up (visits at 1 and 3 years after inclusion). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04578808
Study type Observational
Source Nantes University Hospital
Contact Romain BOURCIER, MD
Phone 33240165608
Email romain.bourcier@chu-nantes.fr
Status Recruiting
Phase
Start date August 19, 2019
Completion date March 15, 2029

See also
  Status Clinical Trial Phase
Recruiting NCT06238115 - Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair Phase 2/Phase 3
Completed NCT05355259 - ACtive Catheterization for EndovaScular TreatmentS N/A
Recruiting NCT05941377 - Enhanced Versus Standard Blood Pressure Lowering on Intracranial Aneurysm Rupture or Growth China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1) N/A
Completed NCT03989557 - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms Phase 4
Recruiting NCT05844163 - Treatment Strategies for Unruptured Intracranial Aneurysms in the Chinese Population China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center